Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorFirst Affiliated Hospital of Wannan Medical College

About this trial

Endovascular therapy (EVT) added on best medical management is currently recommended in acute large vascular occlusion (LVO) stroke patients with National Institutes of Health Stroke Scale (NIHSS) score \>5. Thus, a sizeable fraction of patients with a minor stroke that do not undergo cerebrovascular screening may experience an early neurological deterioration (END) due to LVO, possibly leading to poor long-term functional outcome. However, whether these patients may still benefit from a rescue EVT is unknown, especially in a late window (\>24 hours). In this study, the investigators assume that best medical management plus EVT might be superior than best medical management alone in a late window for minor stroke patients who have experienced an LVO and END. The primary objective of the study was to establish the safety and efficacy of EVT in a late window for minor stroke patients in the anterior circulation who experienced an LVO and END.

Eligibility criteria

Qualifiers

Age ≥ 18 years;

Presenting with symptoms consistent with an AIS and the initial NIHSS score <6 points;

Symptom progression within 7 days of first onset;

Randomization can be finished > 24 hours of stroke onset (stroke onset time is defined as last known well time);

Disqualifiers

Pre-stroke mRS score >1;

Imaging confirms the progression of symptoms caused by intracranial hemorrhage, brain edema, or other clear causes;

The target vessel may have factors that may prevent it from completing endovascular treatment, such as a diameter less than 1.5mm, a tortuous vascular pathway, difficulty in reaching the target position with instruments, or difficulty in recovery;

Severe stenosis or occlusion of multiple blood vessels;

Trial design

Treatments tested in this trial

  • Endovascular therapy
  • Best medical management

Treatment groups

272 Participants
are divided into 2 treatment groups

Sponsors and collaborators

First Affiliated Hospital of Wannan Medical College

Lead sponsor

The First Affiliated Hospital of Anhui Medical University

Collaborator

Xiangtan Central Hospital

Collaborator

The First Affiliated Hospital of Hainan Medical University

Collaborator

Huang Shan People's Hospital

Collaborator

Fuyang people's hospital

Collaborator

Linyi People's Hospital

Collaborator

Jiujiang No.1 People's Hospital

Collaborator

Taihe Hospital

Collaborator